Presently, BPC 157 therapy has still limited but encouraging clinical evidence (no toxicity in clinical trials (i.e., effective in ulcerative colitis, phase II) and toxicology studies without lethal dose (LD1)), and much more should be further achieved [1,2,3,4,5,6,7,8,9,10,11]
The applications listed on this website are suggestions based on medical literature and are for education purposes only
People who struggle with nausea or vomiting on other treatments may tolerate Cagrilintide better
Sold in boxes of 10 vials with a 100-vial order minimum you can mix and match across compounds
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule peptide that functions as a selective NNMT (nicotinamide N-methyltransferase) inhibitor
10.1016/j.yrtph.2020.104665 105 YoussefA